Srinivasa Rao (Paid)
Posts (138)
$30 coming soon.
Just cant believe how these articles are written. Appears to be very biased to bring the share price down
Recent Opioid Litigation Precedents Have Caused More Uncertainty For Endo $ENDP https://seekingalpha.com/article/4292279
Best thing to do is start accumulating
Unbelievable how the stock performed today after all the good news it carried after adcomm. Very interesting!
Offloaded some today at 4:25. Still holding 30K
Added more PM @28.65
Could be a tough day tomorrow
I would say FDA would take until Jan to sort the labeling/REMS for this product. The product will be likely approved only on its PDUFA date probably a week or two early. That said since the labeling/REMS would need to be implemented by the firm based on FDA’s request, the product will likely be available in Late Feb early March. But this is still the best alternative therapy. Carrying Epipen should not be an issue as these patients always carry them. However, ~60% efficacious in terms of resistance building is a positive outcome. The company is also working on egg allergies. Generic competition are less likely in such products. The company will grow from here.
I listened to the entire Adcom. FDA is very interested in approving this product. They were just trying to get more input on what should be part of the REMS. The two negative voters were practicing Physicians. FDA will surely approving this in Jan. I think this will run to $35 in a week, and another $10 after approval + launch of product. Remember this could be potentially be a $1B product peak sales. Let’s hope for the best.